People: Bio-Rad Laboratories Inc (BIO)

BIO on New York Consolidated

118.07USD
17 Sep 2014
Price Change (% chg)

$-0.02 (-0.02%)
Prev Close
$118.09
Open
$118.56
Day's High
$118.95
Day's Low
$117.39
Volume
34,745
Avg. Vol
69,021
52-wk High
$134.13
52-wk Low
$113.72

Search Stocks

Summary

Name Age Since Current Position

Norman Schwartz

64 2012 Chairman of the Board, President, Chief Executive Officer

Christine Tsingos

55 2012 Chief Financial Officer, Executive Vice President

Shawn Soderberg

53 2013 Executive Vice President, General Counsel, Secretary

John Goetz

64 2012 Executive Vice President, President, Clinical Diagnostics Group

Giovanni Magni

57 2012 Executive Vice President, International Sales Manager

Ronald Hutton

56 2012 Vice President, Treasurer

Joel McComb

49 2014 Director

Alice Schwartz

87 1967 Director

Louis Drapeau

70 2007 Independent Director

Robert Malchione

56 2014 Independent Director

Deborah Neff

61 2011 Independent Director

Biographies

Name Description

Norman Schwartz

Mr. Norman D. Schwartz is Chairman of the Board, President, Chief Executive Officer of Bio Rad Laboratories Inc. Mr. Schwartz has been President and Chief Executive Officer since 2003 and Chairman of the Board since 2012. He was Vice President from 1989 to 2002, Group Manager, Life Science, from 1997 to 2002 and Group Manager, Clinical Diagnostics, from 1993 to 1997.

Christine Tsingos

Ms. Christine A. Tsingos is Chief Financial Officer, Executive Vice President of Bio Rad Laboratories Inc. Previously, she was the Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., a provider of information technology asset discovery and management tools, from August 2002 to November 2002. Prior to that, Ms. Tsingos was a consultant to Attest Systems, Inc. from October 2000 to July 2002. She was the Chief Financial Officer at Tavolo, Inc., an online retailer of gourmet cookware and food, from November 1999 to September 2000, and she was Treasurer, and later Vice President and Treasurer, of Autodesk, Inc., a developer of design software, from May 1990 to November 1999.

Shawn Soderberg

Ms. Shawn M. Soderberg is Executive Vice President, General Counsel, Secretary of Bio-Red Laboratories Inc., Previously, she was the Senior Vice President, General Counsel and Secretary of Aricent Group, a global design, engineering services and product software company, from 2006 to 2013. Prior to that, she was Managing Director and General Counsel of H&Q Asia Pacific, a private equity firm, from 2000 to 2006, and Vice President, General Counsel and Secretary of Oak Technology, a semiconductor and embedded solutions provider for the optical storage and the digital home entertainment market, from 1996 to 2000. She was also Vice President and General Counsel of Microtec Research, Inc., a software provider for embedded systems, from 1994 to 1996.

John Goetz

Mr. John Goetz is Executive Vice President, President, Clinical Diagnostics Group of Bio Rad Laboratories Inc. Previously, he held various positions within Bio-Rad since joining in 1974 including Plant Engineer, Manufacturing Manager, Division Manager, Quality Systems Division and Operations Manager of the Diagnostics Group.

Giovanni Magni

Mr. Giovanni Magni is Executive Vice President, International Sales Manager of Bio Rad Laboratories Inc. Previously, he held various positions within Bio-Rad since joining in 1995, including Diagnostic Division Manager, Southern Europe and Diagnostics Group Operation Manager, France.

Ronald Hutton

Mr. Ronald W. Hutton is Vice President, Treasurer of Bio Rad Laboratories Inc. He has been Treasurer since 1997 and was appointed Vice President in 2012. Previously, he was Director of Treasury at Kaiser Aluminum & Chemical Corporation from 1993 to 1997.

Joel McComb

Mr. Joel McComb is Director of the Company. Mr. McComb has 25 years of life science and diagnostics business experience. Since mid-2010 he founded three technology companies in the life science and diagnostics markets under the umbrella of Point Break Capital. The technologies focus on RNA expression, cancer profiling, and pathology. Mr. McComb served as Vice President and General Manager of Illumina, Inc.’s Life Science Business Unit, where he was responsible for leading global product development, business strategy, and overall operations. Prior to joining Illumina, from 2004 through 2008 Mr. McComb held two high level positions at General Electric, serving as President, GE Healthcare Life Sciences-Discovery Systems, and later as President, GE Healthcare, Interventional Medicine. From 2001 through 2004 Mr. McComb was President, CEO, and on the board of Innovadyne Technologies, Inc. Prior to this, Mr. McComb held a series of executive, product development, business and sales positions at Beckman Coulter, Inc. Mr. McComb holds a Bachelor of Science degree in genetics from the University of California, Davis and a Master of Business Administration degree from Golden Gate University.

Alice Schwartz

Mrs. Alice N. Schwartz is Director of Bio Rad Laboratories Inc. Mrs. Schwartz has been retired since 1979. From 1972 to 1978 she was a Research Associate at the University of California. As a co-founder of the Company, Mrs. Schwartz has a unique and invaluable understanding of Company’s business practices and core values.

Louis Drapeau

Mr. Louis Drapeau is an Independent Director of Bio Rad Laboratories Inc. Mr. Drapeau is currently Vice President and Chief Financial Officer of InSite Vision and was Chief Executive Officer of InSite Vision from 2008 to 2010. From 2006 to 2007, he was Senior Vice President and Chief Financial Officer of Nektar Therapeutics. From 2004 to 2005 he was Acting Chief Executive Officer, and from 2002 to 2005 Senior Vice President and Chief Financial Officer, of BioMarin Pharmaceutical. From 1971 to 2002 he was with Arthur Andersen, where he was a Partner from 1983 to 2002 and Managing Partner from 1985 to 1997. He is also a Board member of Intermune, Inc. and AmpliPhi Biosciences Corp., and was a Board member of Inflazyme Pharmaceuticals Ltd. from 2006 to 2008 and of Bionovo, Inc. from 2007 to 2012.

Robert Malchione

Mr. Robert M. Malchione has been appointed as an Independent Director of the comapny., effective January 1, 2014. Mr. Malchione has a broad range of experience in corporate strategy and technology development, most notably at Avery Dennison Corporation, where he served as Senior Vice President, Corporate Strategy and Technology from 2000 to 2011. Prior to that, he served as Vice President, Director and Partner at Boston Consulting Group. Currently, Mr. Malchione is on the Board of Directors and Executive Committee for Innovate Pasadena. He is also an advisor to a start-up company developing system engineering tools for manufacturing companies. Mr. Malchione holds a Master of Business Administration degree from Harvard Graduate School of Business Administration and a Bachelor of Science degree in mechanical engineering from Lehigh University.

Deborah Neff

Ms. Deborah J. Neff serves as an Independent Director of Bio Rad Laboratories Inc., since October 26, 2011. Ms. Neff is currently an executive advisor in the health care industry. From 2006 to 2012, she was President and Chief Executive Officer of Pathwork Diagnostics, Inc. From 2003 to 2006, she was the Chief Executive Officer of Predicant Biosciences. From 1988 to 2003, she served in various positions at BD Biosciences, including as worldwide President from 1995 to 2003.

Basic Compensation

Name Fiscal Year Total

Norman Schwartz

4,565,610

Christine Tsingos

688,241

Shawn Soderberg

--

John Goetz

1,029,050

Giovanni Magni

745,868

Ronald Hutton

--

Joel McComb

--

Alice Schwartz

--

Louis Drapeau

--

Robert Malchione

--

Deborah Neff

--
As Of 30 Dec 2013

Options Compensation

Name Options Value

Norman Schwartz

228,622 4,269,814

Christine Tsingos

25,692 730,525

Shawn Soderberg

0 0

John Goetz

71,507 3,084,535

Giovanni Magni

0 0

Ronald Hutton

0 0

Joel McComb

0 0

Alice Schwartz

0 0

Louis Drapeau

0 0

Robert Malchione

0 0

Deborah Neff

0 0
Search Stocks